🦊/People

Tighe Reardon

Investor

Chief Financial Officer & Managing Partner at Avalon BioVentures · CFO at Avalon Ventures Management, Llc · Board director at AeroRx Therapeutics · Board director at Arialys · Board director at Enlaza Therapeutics

Find your path to Tighe

33 people in our graph share verified history with Tighe — schools, employers, funds. One of them is your warm intro.

Payal DivakaranunlockedTighe: together at AristaMD
×5Tighe: together at Avalon Ventures Management, Llc
×4Tighe: together at AristaMD
Tighe: together at Cellular Approaches

About

Reardon joined Avalon in 2014 and serves as CFO of the firm's Accelerator and its portfolio companies, with over 22 years of senior finance and tax experience. He previously held CFO roles at Synthorx, Sitari Pharmaceuticals, and Calporta, and senior tax and treasury positions at DJO Global and Relational Investors; he is a California CPA with degrees from San Diego State University.

Contact· self-published, not guessed

Board director at AeroRx Therapeutics

Intro paths

In turn, Tighe can intro founders to AeroRx Therapeutics's investors below.

Board director at Arialys

Intro paths

In turn, Tighe can intro founders to Arialys's investors below.

Board director at Enlaza Therapeutics

Intro paths

In turn, Tighe can intro founders to Enlaza Therapeutics's investors below.

Co-founders at Enlaza Therapeutics

SD
Sergio DuronCo-Founder & Chief Executive Officer
SMSanford Madigan
Sanford MadiganCo-Founder, President & Chief Business Officer

Colleagues at Avalon BioVentures

Frequently asked questions

Who is Tighe Reardon?
Reardon joined Avalon in 2014 and serves as CFO of the firm's Accelerator and its portfolio companies, with over 22 years of senior finance and tax experience. He previously held CFO roles at Synthorx, Sitari Pharmaceuticals, and Calporta, and senior tax and treasury positions at DJO Global and Relational Investors; he is a California CPA with degrees from San Diego State University.
Where does Tighe Reardon work?
Tighe Reardon is Chief Financial Officer & Managing Partner at Avalon BioVentures and Board director at AeroRx Therapeutics and Board director at Arialys and Board director at Enlaza Therapeutics.